Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ET-26 vs Etomidate for Induction of General Anesthesia
NCT06203431Phase 3Recruiting
- Sponsor
- Jinzhou Ahon Pharmaceutical Co., Ltd.
- Start
- Oct 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of moxetomidate in general anesthesia, sponsored by Jinzhou Ahon Pharmaceutical Co., Ltd.. Started Oct 2023; status: recruiting.
02
Drugs
moxetomidate
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06203431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06203431.